Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zijin Tougu Spray is a topical Traditional Chinese Medicine (TCM) formulation developed by the Affiliated Hospital of Guizhou Medical University (formerly Guiyang Medical College). It is primarily indicated for the treatment of acute closed soft tissue injuries and joint sprains. The preparation is designed to promote blood circulation, resolve blood stasis, reduce inflammation, and alleviate pain. Pharmacologically, it has been shown to modulate inflammatory mediators, including the reduction of prostaglandin E2 (PGE2) levels and the downregulation of pro-inflammatory cytokines. It is a registered hospital preparation in Guizhou Province, China, and is commonly used in sports medicine and orthopedics for localized relief of swelling and discomfort following trauma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zijin Tougu Spray.